NATCO PHARMA LTD. (NATCOPHARM.BO) Financials
NATCOPHARM.BO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 62.5 billion | 9.6 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 56.6 billion | -34.8 billion |
NATCOPHARM.BO Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 884.0 million | ? |
| 2023-09-30 | 872.0 million | ? |
| 2023-06-30 | 870.0 million | ? |
| 2023-03-31 | 820.0 million | ? |
NATCOPHARM.BO Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 2.1 billion |
| 2023-09-30 | 3.7 billion |
| 2023-06-30 | 4.2 billion |
| 2023-03-31 | 2.8 billion |
NATCOPHARM.BO Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 12.2 billion | 62.0 million | 87.0 million |
| 2023-06-30 | 11.6 billion | - | - |
| 2023-03-31 | 11.6 billion | 11.0 million | 17.0 million |
NATCOPHARM.BO Shares Outstanding
NATCOPHARM.BO Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 1.5 billion | - | 1.2 billion | - |
| 2023-06-30 | - | - | 1.4 billion | - |
| 2023-03-31 | 1.5 billion | 892.0 million | 1.2 billion | 657.0 million |
NATCOPHARM.BO Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 7.6 billion | 1.6 billion |
| 2023-09-30 | 10.3 billion | 2.2 billion |
| 2023-06-30 | 11.4 billion | 2.0 billion |
| 2023-03-31 | 9.0 billion | 2.6 billion |
NATCOPHARM.BO
Price: ₹995.10
Dividend Yield: 0.01%
Forward Dividend Yield: 0.25%
Payout Ratio: 3.53%
Dividend Per Share: 2.50 INR
Earnings Per Share: 70.83 INR
P/E Ratio: 16.85
Exchange: BSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 174.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: 23.52%
DGR5: 15.58%
DGR10: 30.00%